 |
 |

Tick Bites and Lyme Disease in an Endemic Setting
Problematic Use of Serologic Testing and Prophylactic Antibiotic Therapy
Alan D. Fix, MD, MS;
G. Thomas Strickland, MD, PhD;
John Grant, MD, MPH
JAMA. 1998;279:206-210.
Context. The use of serologic testing to diagnose Lyme disease (LD) is a source of controversy. Expert recommendations also discourage the routine use of antibiotic therapy for prophylaxis of LD following tick bites, but the extent to which physicians in endemic areas have adopted these recommendations is not known.
Objective. To assess the pattern of use of serologic testing and antibiotic therapy for tick bites and LD and associated charges for management in an endemic area.
Design. Active surveillance of patient-physician encounters for tick bites and LD.
Setting. Primary care practices on the Eastern Shore of Maryland.
Patients. Consecutive sample of 232 patients with tick bites, LD (defined by physician diagnosis in medical record), and suspected LD (physician notation of possible, but not definite LD) seen in 1995.
Main Outcome Measures. Serologic testing for LD, test results, antibiotic therapy, and direct costs of management.
Results. Surveillance identified 142 patients (61.2%) with diagnoses of tick bites, 40 patients (17.2%) with LD, and 50 patients (21.6%) with suspected LD. Of the 142 patients seen for tick bites, 95 (67%) underwent serologic testing for LD. Of these, 93 patients had initial negative or equivocal results; 24 (26%) of the 93 had convalescent testing, with 1 seroconversion. Seventy-eight patients (55%) with a diagnosis of tick bite received antibiotic therapy. No patients with tick bite developed clinical LD. Serologic testing for LD was performed for 36 patients (90%) with a diagnosis of LD and 46 patients (92%) with suspected LD. In most cases, antibiotics were prescribed before serologic test results became available. Convalescent testing was not performed for 37 (86%) of the 43 patients with suspected LD who had initial negative or equivocal results. Of these 37 patients, 25 (68%) did not receive antibiotic therapy. Direct charges for treatment of these 232 patients totaled $47595, one third of which was attributable to serologic testing. A total of 32% of direct charges were for patients with tick bites, 48% were for patients with LD, and 20% were for patients with suspected LD.
Conclusions. In this setting, most patients consulting physicians for tick bites received prophylactic antibiotic therapy of unproven efficacy and underwent unnecessary, costly serologic testing. Despite almost universal use in this study, serologic testing for LD did not appear to influence treatment of patients diagnosed as having LD.
From the Department of Epidemiology and Preventive Medicine, University of Maryland School of Medicine, Baltimore, Md (Drs Fix and Strickland), and the Kent County Health Department, Chestertown, Md (Dr Grant).
RELATED ARTICLE
Expert Advice and Patient Expectations: Laboratory Testing and Antibiotics for Lyme Disease
Alan G. Barbour
JAMA. 1998;279(3):239-240.
EXTRACT
| FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
 |
Antibiotic Prophylaxis for Lyme Disease: How the Way of Reporting a Clinical Trial Can Alter the Perception of Effectiveness
Gonzalez
Arch Dermatol 2003;139:373-375.
FULL TEXT
Doxycycline for Tick Bites -- Not for Everyone
Shapiro
NEJM 2001;345:133-134.
FULL TEXT
Prevention of Lyme Disease
Committee on Infectious Diseases
Pediatrics 2000;105:142-147.
ABSTRACT
| FULL TEXT
Billions for Defense: The Pervasive Nature of Defensive Medicine
Anderson
Arch Intern Med 1999;159:2399-2402.
FULL TEXT
Role of Serology in the Diagnosis of Lyme Disease
Brown et al.
JAMA 1999;282:62-66.
ABSTRACT
| FULL TEXT
Tick-Borne Pulmonary Disease: Update on Diagnosis and Management
Faul et al.
Chest 1999;116:222-230.
ABSTRACT
| FULL TEXT
Diagnosis, Treatment, and Prevention of Lyme Disease
Bransfield et al.
JAMA 1998;280:1049-1051.
FULL TEXT
Mismanagement of Tick Bites
JWatch Emergency Med. 1998;1998:15-15.
FULL TEXT
Managing Tick Bites Where Lyme Disease Is Endemic
JWatch Infect. Diseases 1998;1998:2-2.
FULL TEXT
Lyme Disease Confusion Abounds
Journal Watch Dermatology 1998;1998:13-13.
FULL TEXT
LYME DISEASE CONFUSION ABOUNDS
JWatch General 1998;1998:2-2.
FULL TEXT
Expert Advice and Patient Expectations: Laboratory Testing and Antibiotics for Lyme Disease
Barbour
JAMA 1998;279:239-240.
FULL TEXT
|